Astellas (Beijing) Pharmaceutical R&D Co., Ltd. clinical trials

A subsidiary of Astellas Pharma Inc

The registry lists 1 studies whose lead sponsor is Astellas (Beijing) Pharmaceutical R&D Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.

Status

Active, not recruiting: 1

Phase

Phase 3: 1

Where

China: 1

Registry sponsor names on this page

Astellas (Beijing) Pharmaceutical R&D Co., Ltd.1 study

Something wrong with this grouping? Tell us on the Astellas Pharma Inc page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Astellas Pharma Inc studies →

An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Active, not recruitingNCT04076059Phase 3
Sponsor listed in the registry: Astellas (Beijing) Pharmaceutical R&D Co., Ltd.